F. Bockstaele, V. Pede, A. Janssens, F. Callewaert, F. Offner et al., Lipoprotein Lipase mRNA Expression in Whole Blood Is a Prognostic Marker in B Cell Chronic Lymphocytic Leukemia, Clinical Chemistry, vol.53, issue.2, pp.204-212, 2007.
DOI : 10.1373/clinchem.2006.076331

M. Kaderi, M. Kanduri, A. Buhl, M. Sevov, N. Cahill et al., LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia, Haematologica, vol.96, issue.8, pp.1153-1160, 2011.
DOI : 10.3324/haematol.2010.039396

S. Kolset and M. Salmivirta, Cell surface heparan sulfate proteoglycans and lipoprotein metabolism, Cellular and Molecular Life Sciences (CMLS), vol.56, issue.9-10, pp.857-870, 1999.
DOI : 10.1007/s000180050031

C. Pallasch, J. Schwamb, S. Konigs, A. Schulz, S. Debey et al., Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells, Leukemia, vol.35, issue.3, pp.585-592, 2008.
DOI : 10.1053/j.seminhematol.2004.05.004

F. Brenet, M. Moh, P. Funk, E. Feierstein, A. Viale et al., DNA Methylation of the First Exon Is Tightly Linked to Transcriptional Silencing, PLoS ONE, vol.20, issue.1, p.14524, 2011.
DOI : 10.1371/journal.pone.0014524.s001

M. Watanabe, Y. Ogawa, K. Itoh, T. Koiwa, M. Kadin et al., Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma, Laboratory Investigation, vol.1519, issue.1, pp.48-57, 2008.
DOI : 10.1038/sj.onc.1207783

M. Bilban, D. Heintel, T. Scharl, T. Woelfel, M. Auer et al., Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression, Leukemia, vol.91, issue.6, pp.1080-1088, 2006.
DOI : 10.1038/sj.leu.2404220

J. Burger, Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting, Seminars in Cancer Biology, vol.20, issue.6, pp.424-430, 2010.
DOI : 10.1016/j.semcancer.2010.09.005

F. Palacios, P. Moreno, P. Morande, C. Abreu, A. Correa et al., High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease, Blood, vol.115, issue.22, pp.4488-4496, 2010.
DOI : 10.1182/blood-2009-12-257758
URL : https://hal.archives-ouvertes.fr/pasteur-00684638